DrPhilipMolyneaux

Faculty of Medicine, National Heart & Lung Institute

Clinical Senior Lecturer in Interstitial Lung Disease

Contact

Location

Sir Alexander Fleming BuildingSouth Kensington Campus

Summary

Dr Philip Molyneaux is a Clinical Senior Lecturer in Interstitial lung disease and an Honorary Consultant at the Royal Brompton Hospital.

Philip qualified from Guy's, King's and St Thomas' School of Medicine in 2004, where he completed an intercalated BSc. in Molecular Genetics. He undertook his SHO training at Guy’s and St Thomas’ and upon completion of the MRCP attained an NIHR Academic Clinical Fellow position in Respiratory medicine at Imperial College. He spent the next two years training at St Mary’s Hospital and working with Professors Cookson, Moffatt and Johnston studying the respiratory microbiome in COPD.

An Asmarley training fellowship allowed him to undertake a PhD examining the host response to the respiratory microbiome in Idiopathic Pulmonary Fibrosis as part of the Prospective Study of Fibrosis In the Lung Endpoints (PROFILE) study with Professors Maher, Cookson and Moffatt.

Having completed his clinical training in Respiratory and Critical Care Medicine he returned to Imperial joining the Fibrosis Research Group as a Senior Clinical Lecturer. He also holds a position as Consultant in Interstitial Lung Disease at the Royal Brompton Hospital where he has a special interest in Familial Pulmonary Fibrosis.

Publications

Journals

Macaluso C, Furcada JM, Alzaher O, et al.Macaluso C, Furcada JM, Alzaher O, Chaube R, Chua F, Wells AU, Maher TM, George PM, Renzoni EA, Molyneaux PL close, 2018, The Potential Impact of Azithromycin in Idiopathic Pulmonary Fibrosis., Eur Respir J

Visca D, Mori L, Tsipouri V, et al.Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoidos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA close, 2018, Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label mixed-method, crossover randomised controlled trial, Lancet Respiratory Medicine, Vol:6, ISSN:2213-2600, Pages:759-770

Celada LJ, Kropski JA, Herazo-Maya JD, et al.Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP close, 2018, PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production., Sci Transl Med, Vol:10

Sun J, Herazo-Maya JD, Molyneaux PL, et al.Sun J, Herazo-Maya JD, Molyneaux PL, Maher TM, Kaminski N, Zhao H close, 2018, Regularized Latent Class Model for Joint Analysis of High Dimensional Longitudinal Biomarkers and A Time-to-Event Outcome., Biometrics

Mallia P, Webber J, Gill SK, et al.Mallia P, Webber J, Gill SK, Trujillo-Torralbo M-B, Calderazzo MA, Finney L, Bakhsoliani E, Fame H, Singanayagam A, Footitt J, Hewitt R, Kebadze T, Aniscenko J, Padmanaban V, Molyneaux PL, Adcock IM, Barnes PJ, Ito K, Elkin SL, Kon OM, Cookson WO, Moffat MF, Johnston SL, Tregoning JS close, 2018, Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease, Journal of Allergy and Clinical Immunology, Vol:142, ISSN:0091-6749, Pages:815-+

More Publications